These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance. Mapara MY; Sykes M J Clin Oncol; 2004 Mar; 22(6):1136-51. PubMed ID: 15020616 [TBL] [Abstract][Full Text] [Related]
5. Tumour immunotherapy: the adjuvant treatment of the 21st century? Bremers AJ; Kuppen PJ; Parmiani G Eur J Surg Oncol; 2000 Jun; 26(4):418-24. PubMed ID: 10873365 [TBL] [Abstract][Full Text] [Related]
6. A prospect on cancer immunology. Kobayashi H Hokkaido Igaku Zasshi; 1979 Nov; 54(6):549-77. PubMed ID: 397163 [TBL] [Abstract][Full Text] [Related]
7. [Antitumor immunity and cellular cancer therapies]. Catros-Quemener V; Bouet F; Genetet N Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191 [TBL] [Abstract][Full Text] [Related]
8. Cancer immunotherapy: the past, the present and the future. Parish CR Immunol Cell Biol; 2003 Apr; 81(2):106-13. PubMed ID: 12631233 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxic immunotherapy strategies for cancer: mechanisms and clinical development. Aguilar LK; Guzik BW; Aguilar-Cordova E J Cell Biochem; 2011 Aug; 112(8):1969-77. PubMed ID: 21465529 [TBL] [Abstract][Full Text] [Related]
10. [Development of novel immunotherapy targeting cancer immune evasion]. Tamada K Gan To Kagaku Ryoho; 2014 Sep; 41(9):1062-5. PubMed ID: 25248888 [TBL] [Abstract][Full Text] [Related]
11. Cancer immunotherapy: a treatment for the masses. Blattman JN; Greenberg PD Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469 [TBL] [Abstract][Full Text] [Related]
12. Immunology and immunotherapy of human cancer: present concepts and clinical developments. Bremers AJ; Parmiani G Crit Rev Oncol Hematol; 2000 Apr; 34(1):1-25. PubMed ID: 10781746 [TBL] [Abstract][Full Text] [Related]
13. [Immune response and cancer]. El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571 [TBL] [Abstract][Full Text] [Related]
14. Immuno-oncology-101: overview of major concepts and translational perspectives. Allard B; Aspeslagh S; Garaud S; Dupont FA; Solinas C; Kok M; Routy B; Sotiriou C; Stagg J; Buisseret L Semin Cancer Biol; 2018 Oct; 52(Pt 2):1-11. PubMed ID: 29428479 [TBL] [Abstract][Full Text] [Related]
15. Can calcium signaling be harnessed for cancer immunotherapy? Rooke R Biochim Biophys Acta; 2014 Oct; 1843(10):2334-40. PubMed ID: 24524821 [TBL] [Abstract][Full Text] [Related]
16. Tumor immune therapy: lessons from infection and implications for cancer - can IL-7 help overcome immune inhibitory networks? Pellegrini M; Mak TW Eur J Immunol; 2010 Jul; 40(7):1852-61. PubMed ID: 20518034 [TBL] [Abstract][Full Text] [Related]
17. [Molecular bases of cancer immunology]. Barrera-RodrÃguez R; Peralta-Zaragoza O; Madrid-Marina V Salud Publica Mex; 1995; 37(4):344-53. PubMed ID: 7502157 [TBL] [Abstract][Full Text] [Related]
19. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology? Fry TJ; Lankester AC Pediatr Clin North Am; 2008 Feb; 55(1):147-67, xi. PubMed ID: 18242319 [TBL] [Abstract][Full Text] [Related]
20. The path to reactivation of antitumor immunity and checkpoint immunotherapy. Kim HJ; Cantor H Cancer Immunol Res; 2014 Oct; 2(10):926-36. PubMed ID: 25281320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]